Enigmatig (EGG) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 4, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2025, filed Feb 17, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the EGG SEC filings page.
Enigmatig Limited (EGG) reported $4.5M in revenue for fiscal year 2025, up 12.2% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (20-F and 6-K reports).
The business keeps gross economics intact, but financing reshaped the balance sheet while operations consumed cash and lost efficiency.
Revenue recovered12.2% in FY2025, yet operating margin fell13.7 pp , showing that the deterioration occurred after gross profit rather than in direct production costs. Gross margin rose1.6 pp while net income fell31.8% , separating resilient gross economics from weaker overall earnings conversion.
FY2025's balance-sheet reset was funded mainly through financing: financing cash flow reached
Cash conversion is the sharper constraint: FY2025 net income was
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Enigmatig Limited's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Enigmatig Limited has an operating margin of 12.1%, meaning the company retains $12 of operating profit per $100 of revenue. This strong profitability earns a score of 77/100, reflecting efficient cost management and pricing power. This is down from 25.8% the prior year.
Enigmatig Limited's revenue grew 12.2% year-over-year to $4.5M, a solid pace of expansion. This earns a growth score of 25/100.
With a current ratio of 8.31, Enigmatig Limited holds $8.31 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 97/100.
Enigmatig Limited's operations used $1.7M of cash, and capex of $246K added to the outflow, for a free cash flow shortfall of $2.0M. This results in a cash flow score of 8/100.
Enigmatig Limited earns a strong 3.5% return on equity (ROE), meaning it generates $4 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 75/100. This is down from 46.1% the prior year.
Enigmatig Limited scores 41.86, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $150.1M against total liabilities of $2.2M. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Enigmatig Limited passes 3 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, 1 of 2 operating efficiency signals passes.
For every $1 of reported earnings, Enigmatig Limited used $3.06 of operating cash (-$1.7M OCF vs $560K net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.
Key Financial Metrics
Earnings & Revenue
Enigmatig Limited generated $4.5M in revenue in fiscal year 2025. This represents an increase of 12.2% from the prior year.
Enigmatig Limited's EBITDA was $571K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 44.5% from the prior year.
Enigmatig Limited reported $560K in net income in fiscal year 2025. This represents a decrease of 31.8% from the prior year.
Enigmatig Limited earned $0.02 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 33.3% from the prior year.
Cash & Balance Sheet
Enigmatig Limited recorded an outflow of $2.0M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. The change from the prior year is not meaningful, because that figure was zero or negative.
Enigmatig Limited held $13.2M in cash as of fiscal year 2025; no long-term debt figure is on record for that period.
Not reported for fiscal year 2025.
Margins & Returns
Enigmatig Limited's gross margin was 68.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 1.6 percentage points from the prior year.
Enigmatig Limited's operating margin was 12.1% in fiscal year 2025, reflecting core business profitability. This is down 13.7 percentage points from the prior year.
Enigmatig Limited's net profit margin was 12.6% in fiscal year 2025, showing the share of revenue converted to profit. This is down 8.1 percentage points from the prior year.
Enigmatig Limited's ROE was 3.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 42.6 percentage points from the prior year.
Capital Allocation
Enigmatig Limited invested $246K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 7500.7% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
EGG Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F |
|---|---|---|---|
| Revenue | $4.5M+12.2% | $4.0M-13.9% | $4.6M |
| Cost of Revenue | $1.4M+6.7% | $1.3M-11.4% | $1.5M |
| Gross Profit | $3.1M+14.9% | $2.7M-15.0% | $3.1M |
| Operating Income | $538K-47.4% | $1.0M-30.9% | $1.5M |
| EBITDA | $571K-44.5% | $1.0M-30.6% | $1.5M |
| Income Tax | $296K+107.8% | $142K-41.4% | $243K |
| Net Income | $560K-31.8% | $821K-27.6% | $1.1M |
| EPS (Basic) | $0.02-33.3% | $0.03-40.0% | $0.05 |
| EPS (Diluted) | $0.02-33.3% | $0.03-40.0% | $0.05 |
| Diluted Shares (Avg) | 26M+3.5% | 25M0.0% | 25M |
Not reported in any period shown, so not listed: R&D Expenses, SG&A Expenses, Interest Expense.
EGG Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F |
|---|---|---|---|
| Total Assets | $18.2M+422.9% | $3.5M-13.5% | $4.0M |
| Current Assets | $15.1M+349.8% | $3.4M | N/A |
| Cash & Equivalents | $13.2M+729.0% | $1.6M+33.6% | $1.2M |
| Short-Term Investments | $0n/m | $0n/m | $0 |
| Accounts Receivable | $1.2M+14.4% | $1.1M | N/A |
| Long-Term Investments | $0n/m | $0n/m | $0 |
| Total Liabilities | $2.2M+30.6% | $1.7M-47.0% | $3.2M |
| Current Liabilities | $1.8M+8.8% | $1.7M | N/A |
| Non-Current Liabilities | $408K+1114.7% | $34K | N/A |
| Total Equity | $16.0M+798.2% | $1.8M+119.1% | $813K |
| Retained Earnings | $2.1M+36.8% | $1.5M | N/A |
Not reported in any period shown, so not listed: Inventory, Goodwill, Long-Term Debt.
EGG Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F |
|---|---|---|---|
| Operating Cash Flow | -$1.7Mn/m | -$603Kn/m | -$59K |
| Depreciation & Amortization | $33K+467.9% | $6K+232.8% | $2K |
| Capital Expenditures | $246K+7500.7% | $3K-20.5% | $4K |
| Free Cash Flow | -$2.0Mn/m | -$606Kn/m | -$63K |
| Investing Cash Flow | -$276K-114.3% | $1.9M+327.2% | $452K |
| Financing Cash Flow | $13.7Mn/m | -$1.1M-405.9% | $347K |
Not reported in any period shown, so not listed: Stock-Based Compensation, Dividends Paid, Share Buybacks.
EGG Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F |
|---|---|---|---|
| Gross Margin | 68.8%+1.6pp | 67.1%-0.9pp | 68.0% |
| Operating Margin | 12.1%-13.7pp | 25.8%-6.3pp | 32.1% |
| Net Margin | 12.6%-8.1pp | 20.7%-3.9pp | 24.6% |
| Return on Equity | 3.5%-42.6pp | 46.1%-93.5pp | 139.6% |
| Return on Assets | 3.1%-20.5pp | 23.6%-4.6pp | 28.2% |
| Current Ratio | 8.31+6.3x | 2.01 | N/A |
| Liabilities-to-Equity | 0.14-0.8x | 0.96-3.0x | 3.96 |
| Asset Turnover | 0.24-0.9x | 1.140.0x | 1.14 |
| FCF Margin | -44.1%-28.8pp | -15.3%-13.9pp | -1.4% |
Not reported in any period shown, so not listed: Debt-to-Equity.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Enigmatig Limited EGG | FY2025 | $4.5M | $560K | 12.6% | $150.1M | 60/100 |
| Forrester Research Inc FORR | FY2025 | $396.9M | -$119.4M | -30.1% | $178.2M | 29/100 |
| Resources Connection RGP | FY2026 | $452.0M | -$40.6M | -9.0% | $93.7M | 32/100 |
| Roma Green Finance Limited ROMA | FY2026 | $1.2M | -$3.5M | N/A | $386.6M | 49/100 |
| SBC Medical Group Holdings Incorporated SBC | FY2025 | $173.6M | $51.0M | 29.4% | $547.1M | 76/100 |
| Acco Group Holdings Limited ACCL | FY2026 | $5.1M | $286K | 5.6% | $34.9M | 76/100 |
Where Enigmatig Limited Ranks
Frequently Asked Questions
Enigmatig Limited (EGG) reported $4.5M in total revenue for fiscal year 2025. This represents a 12.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Enigmatig Limited (EGG) revenue grew by 12.2% year-over-year, from $4.0M to $4.5M in fiscal year 2025.
Yes, Enigmatig Limited (EGG) reported a net income of $560K in fiscal year 2025, with a net profit margin of 12.6%.
Enigmatig Limited (EGG) had EBITDA of $571K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
Enigmatig Limited (EGG) had a gross margin of 68.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
Enigmatig Limited (EGG) had an operating margin of 12.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
Enigmatig Limited (EGG) had a net profit margin of 12.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Enigmatig Limited (EGG) has a return on equity of 3.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
Enigmatig Limited (EGG) recorded an outflow of $2.0M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
Enigmatig Limited (EGG) recorded an outflow of $1.7M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
Enigmatig Limited (EGG) had $18.2M in total assets as of fiscal year 2025, including both current and long-term assets.
Enigmatig Limited (EGG) invested $246K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
Enigmatig Limited (EGG) had a current ratio of 8.31 as of fiscal year 2025, which is generally considered healthy.
Enigmatig Limited (EGG) had a liabilities-to-equity ratio of 0.14 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.
Enigmatig Limited (EGG) had a return on assets of 3.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Enigmatig Limited (EGG) trades at 268x earnings, its market capitalization divided by $560K net income, FY2025. The market capitalization is $150.1M as of Nov 4, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Enigmatig Limited (EGG) trades at 33.7x sales, its market capitalization divided by $4.5M revenue, FY2025. The market capitalization is $150.1M as of Nov 4, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
At the end of fiscal year 2025, Enigmatig Limited (EGG) held $13.2M in cash, cash equivalents and investments, and reported an operating cash outflow of $1.7M over that year. Dividing the one by the other, the reported balance equals about 92 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Enigmatig Limited (EGG) has an Altman Z-Score of 41.86, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
Enigmatig Limited (EGG) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
For every $1 of reported earnings, Enigmatig Limited (EGG) used $3.06 of operating cash (-$1.7M OCF vs $560K net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Enigmatig Limited (EGG) scores 60 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.